19.01.2013 Views

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Natuurkundige <strong>voor</strong>drachten I Nieuwe reeks 89<br />

Migraine: de ontrafeling van een complexe ziekte<br />

114<br />

‘<strong>no</strong>rmal’ migraine with or without aura.<br />

Thus, from a clinical perspective, FHM seems a<br />

valid model for the common forms of migraine both<br />

with and without aura.<br />

However, it bears mentioning that in 20% of cases,<br />

FHMmay also be associated with cerebellar ataxia<br />

and other neurological symptoms such as epilepsy,<br />

mental retardation, brain edema, and (sometimes<br />

fatal) coma. To date, three genes for FHM have<br />

been identified, and, based on unpublished linkage<br />

results in several families, there are likely more to<br />

come. These genes are discussed below.<br />

A. The FHM1 CACNA1A gene<br />

In 1996, the first gene linked to FHM was identified<br />

as the CACNA1A gene on chromosome 19p13.<br />

Responsible for approximately half of all families<br />

with FHM, the FHM1 gene encodes the ion-conducting,<br />

poreforming α1A subunit of CaV2.1, a neuronal<br />

voltage-gated calcium channel. The main function<br />

of CaV2.1 (P/Q-type) calcium channels is to trigger<br />

the release of neurotransmitters, both at central<br />

synapses and at the neuromuscular junction. Over<br />

50 mutations in CACNA1A have been associated<br />

with a wide range of clinical phe<strong>no</strong>types, including<br />

both pure FHM and combinations of FHM with<br />

various degrees of cerebellar ataxia and fatal coma<br />

due to excessive cerebral edema. Mutations in the<br />

CACNA1A gene have also been linked to disorders<br />

<strong>no</strong>t associated with FHM, including episodic ataxia<br />

type 2 (EA2), progressive ataxia, spi<strong>no</strong>cerebellar<br />

ataxia type 6, and both absence and generalized<br />

epilepsy. Interestingly, in several FHM families,<br />

FHM1 CACNA1A mutations were also found in family<br />

members who did <strong>no</strong>t exhibit FHM but instead<br />

exhibited ‘<strong>no</strong>rmal’ <strong>no</strong>nparetic migraine, suggesting<br />

that gene mutations for FHM may also be responsible<br />

for the common forms of migraine, possibly due<br />

to the contributions of different genetic and <strong>no</strong>ngenetic<br />

modulatory factors.<br />

B. The FHM2 ATP1A2 gene<br />

The second gene identified for FHM does <strong>no</strong>t code<br />

for an ion channel, but rather for a transporter that<br />

catalyzes the exchange of Na + and K + across the<br />

cell membrane. The ATP1A2 gene on chromosome<br />

1q23 encodes the α2 subunit of a Na + /K + -ATPase.<br />

This enzyme utilizes ATP hydrolysis to transport Na +<br />

ions out of the cell in exchange for K + ions into the<br />

cell, thereby providing the steep Na + gradient essential<br />

for the transport of glutamate and Ca2+ . During<br />

development, ATP1A2 is predominantly expressed in<br />

neurons, but expression shifts to glial cells by adulthood.<br />

In adults, an important function of this specific<br />

ATPase is to modulate the removal of potassium and<br />

glutamate from the synaptic cleft into the glial cell.<br />

Mutations in the ATP1A2 gene cause at least 20%<br />

of FHM cases and have been associated with pure<br />

FHM, as well as with FHM together with cerebellar<br />

ataxia, alternating hemiplegia of childhood, benign<br />

familial infantile convulsions and other forms of<br />

epilepsy. Interestingly, in an Italian family, a variant<br />

in the ATP1A2 gene segregated with basilar<br />

migraine, a subtype of MA characterized by aura<br />

symptoms attributable to the brainstem and both<br />

occipital lobes. However, <strong>no</strong> functional studies were<br />

reported, precluding a definite conclusion as to<br />

whether this gene variation is also causally linked<br />

to basilar migraine. It is also interesting to <strong>no</strong>te that<br />

ATP1A2 variants were identified in two <strong>no</strong>n-FHM<br />

migraine families, suggesting that this genemay<br />

play an important role in the susceptibility to common<br />

forms of migraine.<br />

C. The FHM3 SCN1A gene<br />

The most recent FHM gene identified is SCN1A on<br />

chromosome 2q24.<br />

This gene encodes the α subunit of a neuronal<br />

NaV1.1 sodium channel. Voltage-gated sodium channels<br />

are primarily responsible for the generation and<br />

propagation of action potentials in excitable cells. In<br />

the brain, NaV1.1 channels are expressed primarily on<br />

inhibitory neurons, and their absence leads to severe<br />

ataxia and seizures, presumably due to increased<br />

neuronal excitability. Different mutations in SCN1A<br />

are k<strong>no</strong>wn to be associated with childhood epilepsy<br />

and febrile seizures.<br />

D. Sporadic hemiplegic migraine (SHM)<br />

Hemiplegic migraine patients are <strong>no</strong>t always clus-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!